LONDON--(MARKET WIRE)--Dec 7, 2007 -- David Brennan, AstraZeneca CEO, and senior management from AstraZeneca and MedImmune discuss opportunities in the biologics field, R&D and portfolio progress plus the Group’s current focus and priorities. The interviews and transcripts are available now on www.cantos.com.
Interviewees: David Brennan, CEO, AstraZeneca David Mott, CEO, MedImmune Dr John Patterson, Development Director, AstraZeneca Jim Young, Head of R&D, MedImmune
This programming is available in video, audio and transcript. It’s free to view. All you need to do is register at www.cantos.com . Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses. If you would like to contact us, please email enquiries@cantos.com.
Copyright © Hugin ASA 2007. All rights reserved.
Contact: Source: AstraZeneca
